So I ran across this stuff recently, and it seems to have some strong anecdotal support for it's anti-viral effects. I believe Duke uses, or used to use this stuff.
http://www.lifelinkn...roducts/BHT.aspIn BHT's other function, as a membrane manipulator, molecules of BHT merge with the lipid membranes of cells and of viruses that have lipid envelopes (such as the herpes virus). The presence of enough BHT molecules in a viral envelope can alter the envelope's physical properties enough to make the viral particle incapable of infecting a human cell. This can bring a halt to a viral infection's spread within the body.
What is BHT good for?
According to the medical research literature, BHT can be useful for:
- preventing viral infections, such as herpes, and terminating their outbreaks3,4,5,6
- prevention of DNA damage and cancer by certain carcinogens7,8,9
- protection of the brain from damage by alcohol10
- increasing the tissue concentrations of Vitamin E11
- preventing birth defects in diabetic pregnancies12
- preventing atherosclerosis13
- protection from manganese toxicity14
http://drzarkov.com/...-antiviral.htmlBHT's Use as an Antiviral Based on an article by Ed Sharpe A little over 25 years ago a paper was published in the journal Science showing that BHT, a common food preservative, could inactivate herpes simplex and other lipid-coated viruses in lab dishes 1. Two years later another paper in the same journal reported similar results, but this time in live animals — dietary BHT could prevent chickens from dying of Newcastle disease 2. Like herpes simplex, NDV (the virus that causes Newcastle disease) is lipid-enveloped — its nucleic acid core is sheathed in a fatty membrane. Viruses of this type require an intact membrane to be infective. BHT seems to work against such viruses by disrupting their viral membranes.
In the chicken study cited above, the amount of BHT needed to inhibit NDV turned out to be equal to the amount already present in chicken feed as an additive, i.e., 100 to 200 parts per million of total diet 2. Assuming a comparable result for humans and a total food intake of about 2 kilograms per day, this would mean that 200 to 400 milligrams of BHT ingested daily should be adequate to protect most people from infection by herpes and other lipid-coated viruses.
Inspired by early scientific reports on the antiviral activity of BHT, a number of people suffering from herpes began to experiment on themselves in the late 1970s. As described in several books published a few years later, the BHT experimenters discovered that a daily dose of 250 to 1000 mg resulted in rapid recovery from herpes eruptions with no recurrences 3, 4.
Studies performed since then have confirmed the activity of BHT against many different human and animal viruses, including such members of the herpes family as CMV (cytomegalovirus) 5, pseudorabies 6 and genital herpes 7. BHT appears to inhibit infectivity of HIV 8, the AIDS virus, although contradictory results have also been reported 9. A protective effect of BHT against the development of influenza infection has been shown 10, 11. The mechanism involved may have to do with the fact that BHT is a highly potent, membrane-active antioxidant as well as a membrane fluidizer. It's known that reactive oxygen species (ROS) play a role in the pathogenesis of viral infections — including RNA viruses such as influenza, DNA viruses such as hepatitis B, and retroviruses such as HIV — and it's been suggested that antioxidants may be useful as therapeutic agents in such infections 12.
It's even a weak mitochondrial uncoupler, and it might help with weight loss.
Mitochondrial uncouplers with an extraordinary dynamic range
Phing-How Lou,* Birgit S. Hansen,† Preben H. Olsen,† Søren Tullin,† Michael P. Murphy,* and Martin D. Brand*1
Abstract
We have discovered that some weak uncouplers (typified by butylated hydroxytoluene) have a dynamic range of more than 106 in vitro: the concentration giving measurable uncoupling is less than one millionth of the concentration causing full uncoupling. They achieve this through a high-affinity interaction with the mitochondrial adenine nucleotide translocase that causes significant but limited uncoupling at extremely low uncoupler concentrations, together with more conventional uncoupling at much higher concentrations. Uncoupling at the translocase is not by a conventional weak acid/anion cycling mechanism since it is also caused by substituted triphenylphosphonium molecules, which are not anionic and cannot protonate. Covalent attachment of the uncoupler to a mitochondrially targeted hydrophobic cation sensitizes it to membrane potential, giving a small additional effect. The wide dynamic range of these uncouplers in isolated mitochondria and intact cells reveals a novel allosteric activation of proton transport through the adenine nucleotide translocase and provides a promising starting point for designing safer uncouplers for obesity therapy.
Edited by rwac, 28 July 2010 - 11:02 PM.